Literature DB >> 32301221

A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity.

Andy Goren1, Sergio Vaño-Galván2, Carlos Gustavo Wambier3, John McCoy1, Alba Gomez-Zubiaur4, Oscar M Moreno-Arrones2, Jerry Shapiro5, Rodney D Sinclair6, Michael H Gold7, Maja Kovacevic8, Natasha Atanaskova Mesinkovska9, Mohamad Goldust10, Ken Washenik5,11.   

Abstract

A preliminary observation of high frequency of male pattern hair loss among admitted COVID-19 patients and suggest that androgen expression might be a clue to COVID-19 severity.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  5-alpha reductase; ACE2; SARS-CoV-2; TMPRSS2; androgenetic alopecia

Mesh：

Substances：

Year:  2020        PMID： 32301221     DOI： 10.1111/jocd.13443

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN： 1473-2130            Impact factor:   2.696


  66 in total

Review 1.  Familiar dermatologic drugs as therapies for COVID-19.

Authors:  M Ortega-Peña; R González-Cuevas
Journal:  Actas Dermosifiliogr       Date:  2020-12-23

Review 2.  Androgens in SARS-CoV-2 coronavirus infections.

Authors:  L Stárka; M Dušková
Journal:  Physiol Res       Date:  2021-12-16       Impact factor: 1.881

Review 3.  Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis.

Authors:  Jean Kim; Kyle Miyazaki; Parthav Shah; Landon Kozai; Jakrin Kewcharoen
Journal:  Healthcare (Basel)       Date:  2022-03-30

4.  A Deep Language Model for Symptom Extraction From Clinical Text and its Application to Extract COVID-19 Symptoms From Social Media.

Authors:  Xiao Luo; Priyanka Gandhi; Susan Storey; Kun Huang
Journal:  IEEE J Biomed Health Inform       Date:  2022-04-14       Impact factor: 7.021

Review 5.  Sex differences in COVID-19: the role of androgens in disease severity and progression.

Authors:  Mohamed S Mohamed; Thiago C Moulin; Helgi B Schiöth
Journal:  Endocrine       Date:  2020-11-11       Impact factor: 3.633

6.  Extraordinary claims without extraordinary evidence: controversy on anti-androgen therapy for COVID-19.

Authors:  R M Trüeb; A Régnier; N Caballero-Uribe; M F Reis Gavazzoni Dias; H Dutra Rezende
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-04-08       Impact factor: 9.228

Review 7.  Are sex discordant outcomes in COVID-19 related to sex hormones?

Authors:  Jonathan D Strope; Cindy H Chau; William D Figg
Journal:  Semin Oncol       Date:  2020-06-17       Impact factor: 4.929

8.  Male balding is a major risk factor for severe COVID-19.

Authors:  Justin Lee; Ahmed Yousaf; Wei Fang; Michael S Kolodney
Journal:  J Am Acad Dermatol       Date:  2020-07-22       Impact factor: 11.527

Review 9.  Skin disorders associated with the COVID-19 pandemic: A review.

Authors:  Jennifer Akl; Jessica El-Kehdy; Antoine Salloum; Anthony Benedetto; Paula Karam
Journal:  J Cosmet Dermatol       Date:  2021-07-01       Impact factor: 2.189

Review 10.  Androgenetic alopecia and COVID-19: A review of the hypothetical role of androgens.

Authors:  Hamideh Moravvej; Mohammad Reza Pourani; Moein Baghani; Fahimeh Abdollahimajd
Journal:  Dermatol Ther       Date:  2021-06-09       Impact factor: 3.858
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.